| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5902182 | Journal of Diabetes and its Complications | 2016 | 7 Pages |
Abstract
Better outcome in neuropathic impairments following 4-year treatment with α-lipoic acid was predicted by normal BMI and blood pressure and higher burden due to CVD, diabetes, and neuropathy, while improvement in cardiac autonomic function was predicted by ACE inhibitor treatment. Thus, optimal control of CVD risk factors could contribute to improved efficacy of α-lipoic acid in patients with higher disease burden.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Dan Ziegler, Phillip A. Low, Roy Freeman, Hans Tritschler, Aaron I. Vinik,